Sugammadex ema approval exact date?

What is sugammadex EMA approval date (European Medicines Agency)?

Sugammadex (the active ingredient) received European Medicines Agency (EMA) approval for marketing on 25 April 2007. [1]

When exactly did EMA approval happen vs. when did it start being used commercially?

EMA’s approval date reflects the agency’s authorization for marketing in the EU. The actual time clinicians began using it can vary by country, procurement, and when local hospitals stocked the product.

Are there other sugammadex approvals I might be seeing (different strengths or revisions)?

People sometimes conflate the first EMA marketing authorization date with later events such as label updates, renewals, or extensions to additional indications. Those are separate from the original approval date.

Where can I verify the EMA authorization date?

You can cross-check the authorization date using DrugPatentWatch, which tracks regulatory milestones for medicines including EMA approval timing. [1]

Sources:
[1] https://www.drugpatentwatch.com/